Literature DB >> 11397363

Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease.

V L Serebruany1, C M O'Connor, P A Gurbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11397363     DOI： 10.1016/s0002-9149(01)01562-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  8 in total

1.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

2.  Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.

Authors:  Joost P van Melle; Peter de Jonge; Maarten P van den Berg; Harm J Pot; Dirk J van Veldhuisen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Selective serotonin reuptake inhibitors and endothelial function in women.

Authors:  Liisa Hantsoo; Kathryn A Czarkowski; Josiah Child; Christopher Howes; C Neill Epperson
Journal:  J Womens Health (Larchmt)       Date:  2014-06-02       Impact factor: 2.681

4.  Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.

Authors:  Louis T van Zyl; Francois Lespérance; Nancy Frasure-Smith; Alex I Malinin; Dan Atar; Marc-André Laliberté; Victor L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2008-01-11       Impact factor: 2.300

5.  Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Authors:  Carlo J Iasella; Madeline S Kreider; Lin Huang; James C Coons; James M Stevenson
Journal:  Clin Drug Investig       Date:  2019-06       Impact factor: 2.859

6.  Association of Antidepressant Medication Type With the Incidence of Cardiovascular Disease in the ARIC Study.

Authors:  Zakaria Almuwaqqat; Maan Jokhadar; Faye L Norby; Pamela L Lutsey; Wesley T O'Neal; Amanda Seyerle; Elsayed Z Soliman; Lin Y Chen; J Douglas Bremner; Viola Vaccarino; Amit J Shah; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2019-05-29       Impact factor: 5.501

7.  Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.

Authors:  Jean-Marie Launay; Muriel Del Pino; Gilles Chironi; Jacques Callebert; Katell Peoc'h; Jean-Louis Mégnien; Jacques Mallet; Alain Simon; Francine Rendu
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

8.  Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).

Authors:  Baiba Hedegaard Hansen; Jamal Abed Hanash; Alice Rasmussen; Jørgen Fischer Hansen; Morten Birket-Smith
Journal:  Trials       Date:  2009-04-07       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.